Mera Pharmaceuticals Inc. Stock Analysis MRPI

Mera Pharmaceuticals, Inc. is a marine biotechnology company. The company is headquartered in Kailua-Kona, Hawaii. The company went IPO on 2002-06-13. The firm focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The firm manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The firm also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The firm offers nigari in sizes ranging from one gallon to 250 gallons.